Macquarie Group Ltd

SEC CIK: 0001418333
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overview All 13F holders of REGN Full Q2 2026 holdings

Shares (Q2 2026): 17,532
Value: $10.9M
% of portfolio: <0.1%
Quarters held: 22; Since Q1 2021

Holdings of REGN by Macquarie Group Ltd, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	17,532	$10.9M	<0.1%	+4,482+34.3%	Added	Holders
Q1 2026	13,050	$10.1M	0.1%	−20,767−61.4%	Reduced	Holders
Q4 2025	33,817	$26.1M	0.1%	−52,851−61.0%	Reduced	Holders
Q3 2025	86,668	$48.7M	0.1%	+9,943+13.0%	Added	Holders
Q2 2025	76,725	$40.3M	<0.1%	−2,113−2.7%	Reduced	Holders
Q1 2025	78,838	$50.0M	0.1%	−175−0.2%	Reduced	Holders
Q4 2024	79,013	$53.4M	0.1%	+3,872+5.2%	Added	Holders
Q3 2024	75,141	$79.0M	0.1%	−1,284−1.7%	Reduced	Holders
Q2 2024	76,425	$80.3M	0.1%	−423−0.6%	Reduced	Holders
Q1 2024	76,848	$74.0M	0.1%	−1,890−2.4%	Reduced	Holders
Q4 2023	78,738	$69.2M	0.1%	−23,013−22.6%	Reduced	Holders
Q3 2023	101,751	$83.7M	0.1%	+498+0.5%	Added	Holders
Q2 2023	101,253	$72.8M	0.1%	−69,846−40.8%	Reduced	Holders
Q1 2023	171,099	$140.6M	0.2%	−68,587−28.6%	Reduced	Holders
Q4 2022	239,686	$172.9M	0.2%	−18,887−7.3%	Reduced	Holders
Q3 2022	258,573	$178.1M	0.2%	−20,339−7.3%	Reduced	Holders
Q2 2022	278,912	$164.9M	0.2%	−5,396−1.9%	Reduced	Holders
Q1 2022	284,308	$198.6M	0.2%	+10,575+3.9%	Added	Holders
Q4 2021	273,733	$172.9M	0.1%	+55,802+25.6%	Added	Holders
Q3 2021	217,931	$131.9M	0.1%	+111,854+105.4%	Added	Holders
Q2 2021	106,077	$59.2M	<0.1%	+2,865+2.8%	Added	Holders
Q1 2021	103,212	$48.8M	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.